| Synonyms: | |
| Status: | Approved (1997) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent Prodrug |
| ATC: | B01AC04 |
| UNII: | A74586SNO7 |
| InChI Key | GKTWGGQPFAXNFI-HNNXBMFYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C16H16ClNO2S |
| Molecular Weight | 321.83 |
| AlogP | 3.67 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 29.54 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 21.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2B
Cytochrome P450 2B6
|
- | - | - | 500-1100 | 44 | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C19
|
- | - | - | 14300 | 10 | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
- | - | - | - | 35 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Thrombosis | 4 | D013927 | ClinicalTrials |
| Myocardial Infarction | 3 | D009203 | ClinicalTrials |
| Coronary Disease | 3 | D003327 | ClinicalTrials |
| Carotid Stenosis | 3 | D016893 | ClinicalTrials |
| Peripheral Arterial Disease | 3 | D058729 | ClinicalTrials |
| Acute Coronary Syndrome | 3 | D054058 | ClinicalTrials |
| Atrial Fibrillation | 3 | D001281 | ClinicalTrials |
| Hemorrhage | 3 | D006470 | ClinicalTrials |
| Ischemia | 3 | D007511 | ClinicalTrials |
| Stroke | 3 | D020521 | ClinicalTrials |
| Renal Insufficiency, Chronic | 3 | D051436 | ClinicalTrials |
| Atherosclerosis | 3 | D050197 | ClinicalTrials |
| Heart Failure | 3 | D006333 | ClinicalTrials |
| Vascular Diseases | 3 | D014652 | ClinicalTrials |
| Angina, Stable | 3 | D060050 | ClinicalTrials |
| Aortic Valve Stenosis | 3 | D001024 | ClinicalTrials |
| Ischemic Attack, Transient | 3 | D002546 | ClinicalTrials |
| Intracranial Aneurysm | 3 | D002532 | ClinicalTrials |
| Intracranial Arteriosclerosis | 3 | D002537 | ClinicalTrials |
| ST Elevation Myocardial Infarction | 3 | D000072657 | ClinicalTrials |
| Arteriosclerosis | 3 | D001161 | ClinicalTrials |
| Thrombophilia | 3 | D019851 | ClinicalTrials |
| Heart Defects, Congenital | 3 | D006330 | ClinicalTrials |
| Gastrointestinal Hemorrhage | 3 | D006471 | ClinicalTrials |
| Brain Infarction | 3 | D020520 | ClinicalTrials |
| Ischemic Stroke | 3 | D000083242 | ClinicalTrials |
| Myocardial Infarction | 3 | D009203 | ClinicalTrials |
| Venous Thromboembolism | 2 | D054556 | ClinicalTrials |
| Intermittent Claudication | 2 | D007383 | ClinicalTrials |
| Peripheral Vascular Diseases | 2 | D016491 | ClinicalTrials |
| Asthma | 2 | D001249 | ClinicalTrials |
| HIV Infections | 2 | D015658 | ClinicalTrials |
| Hypertension, Pulmonary | 2 | D006976 | ClinicalTrials |
| Polycythemia Vera | 2 | D011087 | ClinicalTrials |
| HIV Infections | 2 | D015658 | ClinicalTrials |
| Pneumonia, Viral | 2 | D011024 | ClinicalTrials |
| Pregnancy | 2 | D011247 | ClinicalTrials |
| Respiratory Insufficiency | 2 | D012131 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Heart Diseases | 2 | D006331 | ClinicalTrials |
| Head and Neck Neoplasms | 1 | D006258 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 1 | D003924 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 1 | D008180 | ClinicalTrials |
| Depressive Disorder, Major | 1 | D003865 | ClinicalTrials |
| Cardiovascular Diseases | 1 | D002318 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 113665-84-2 |
| ChEBI | 37941 |
| ChEMBL | CHEMBL1771 |
| DrugBank | DB00758 |
| DrugCentral | 708 |
| EPA CompTox | DTXSID6022848 |
| FDA SRS | A74586SNO7 |
| Human Metabolome Database | HMDB0005011 |
| Guide to Pharmacology | 7150 |
| KEGG | D07729 |
| PDB | CGE |
| PharmGKB | PA449053 |
| PubChem | 60606 |
| SureChEMBL | SCHEMBL4769 |
| ZINC | ZINC000034781704 |